- Article metrics
- Last updated: Tue, 7 Apr 2026 7:23:43 Z
DTX3L promotes ovarian cancer progression and cisplatin resistance by activating JAK1/STAT1/OAS3 pathway
Access & Citations
-
- 140
- Article Accesses
-
- Not available
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
